Verified peer comparison
Canterbury Park Holding vs Spero Therapeutics Financial Comparison
Direct answer
Canterbury Park Holding and Spero Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Canterbury Park Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Canterbury Park Holding Revenue
- 59,567,585 USD
- Spero Therapeutics Revenue
- 59,619,000 USD
- Canterbury Park Holding Operating income
- 2,517,866 USD
- Spero Therapeutics Operating income
- -24,000 USD